Globus Medical (GMED) Q2 2024 Earnings Call Transcript
The Motley Fool
AUGUST 6, 2024
Globus delivered another robust post-merger quarter in Q2 with sales of $630 million, growing 116% or $338 million. Non-GAAP EPS was $0.75, increasing 20% versus prior year even with the 35% increase in outstanding shares driven by the merger. Scavilla -- President, Chief Executive Officer, and Director Thanks, Brian. revenue grew 3.1%
Let's personalize your content